Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Asmanex Twisthaler launched in U.K.

Jan. 23, 2003

Scientists at Boehringer Ingelheim present novel tachykinin antagonists and their uses

Jan. 23, 2003

Chiesi's budesonide Modulite pMDI approved in Germany

Jan. 21, 2003

Novartis and Ivax sign Airmax inhaler agreement for respiratory products

Jan. 21, 2003

AstraZeneca's Oxis Turbuhaler completes mutual recognition procedure for COPD

Jan. 17, 2003

Novel series of adenosine A3 antagonists in early development at Sanofi-Synthelabo

Jan. 16, 2003

Alpha Therapeutic receives FDA approval for Aralast

Jan. 16, 2003

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Jan. 16, 2003

First U.S. clinical trial of Rigel antiallergy drug

Jan. 15, 2003

Novel inhibitors of VLA-4-mediated cell adhesion described in recent patent

Jan. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026